BMC Cancer 2009, 9:438 http://www.biomedcentral.com/1471-2407/9/438 References 1. Lonard DM, O'Malley BW: The expanding cosmos of nuclear receptor coactivators. Cell 2006, 125(3):411-414. 2. O'Malley BW: Coregulators: from Whence Came These 'Mas- ter Genes'. Mol Endocrinol 2007, 21(5):1009-13. 3. Lonard DM, O'Malley BW: Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell 2007, 27(5):691-700. 4. Lonard DM, Lanz RB, O'Malley BW: Nuclear receptor coregula- tors and human disease. Endocr Rev 2007, 28(5):575-587. 5. Agoulnik IU, Vaid A, Bingman WE, Erdeme H, Frolov A, Smith CL, Ayala G, Ittmann MM, Weigel NL: Role of SRC-1 in the promo- tion of prostate cancer cell growth and tumor progression. Cancer Res 2005, 65(17):7959-7967. 6. Chopra AR, Louet JF, Saha P, An J, Demayo F, Xu J, York B, Karpen S, Finegold M, Moore D, et al.: Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science 2008, 322(5906):1395-1399. 7. Myers E, Fleming FJ, Crotty TB, Kelly G, McDermott EW, O'Higgins NJ, Hill AD, Young LS: Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer. British journal of cancer 2004, 91(9):1687-1693. 8. Redmond AM, Bane FT, Stafford AT, McIlroy M, Dillon MF, Crotty TB, Hill AD, Young LS: Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recur- rence. Clin Cancer Res 2009, 15(6):2098-2106. 9. Sakaguchi H, Fujimoto J, Sun WS, Tamaya T: Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endome- trial cancers. The Journal of steroid biochemistry and molecular biology 2007, 104(3-5):237-240. 10. Wang S, Yuan Y, Liao L, Kuang SQ, Tien JC, O'Malley BW, Xu J: Dis- ruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation. Proc Natl Acad Sci USA 2009, 106(1):151-156. 11. Breast Cancer Facts & Figures 2007-2008. . 12. Houlston RS, Peto J: The search for low-penetrance cancer sus- ceptibility alleles. Oncogene 2004, 23(38):6471-6476. 13. Tchatchou S, Jung A, Hemminki K, Sutter C, Wappenschmidt B, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, et al.: A variant affecting a putative miRNA target site in estro- gen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 2009, 30(1):59-64. 14. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, Rod- riguez R, Barbosa-Morais NL, Ponder BA, Low YL, et al.: Association of ESR1 gene tagging SNPs with breast cancer risk. Human molecular genetics 2009, 18(6):1131-1139. 15. Burwinkel B, Wirtenberger M, Klaes R, Schmutzler RK, Grzybowska E, Forsti A, Frank B, Bermejo JL, Bugert P, Wappenschmidt B, et al.: Association of NCOA3 polymorphisms with breast cancer risk. Clin Cancer Res 2005, 11(6):2169-2174. 16. Haiman CA, Garcia RR, Hsu C, Xia L, Ha H, Sheng X, Le Marchand L, Kolonel LN, Henderson BE, Stallcup MR, et al.: Screening and asso- ciation testing of common coding variation in steroid hor- mone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort. BMC cancer 2009, 9:43. 17. Yang R, Frank B, Hemminki K, Bartram CR, Wappenschmidt B, Sutter C, Kiechle M, Bugert P, Schmutzler RK, Arnold N, et al.: SNPs in ultraconserved elements and familial breast cancer risk. Car- cinogenesis 2008, 29(2):351-355. 18. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68(4):978-989. 19. Park J, Hwang S, Lee YS, Kim SC, Lee D: SNP@Ethnos: a database of ethnically variant single-nucleotide polymorphisms. Nucleic acids research 2007:D711-715. 20. Gorlov IP, Gorlova OY, Amos CI: Relative effects of mutability and selection on single nucleotide polymorphisms in tran- scribed regions of the human genome. BMC genomics 2008, 9:292. 21. Prendergast JG, Campbell H, Gilbert N, Dunlop MG, Bickmore WA, Semple CA: Chromatin structure and evolution in the human genome. BMC evolutionary biology 2007, 7:72. 22. Meulenbelt I, Chapman K, Dieguez-Gonzalez R, Shi D, Tsezou A, Dai J, Malizos KN, Kloppenburg M, Carr A, Nakajima M, et al.: Large Replication Study and Meta-Analyses of Dvwa as an Osteoar- thritis Susceptibility Locus in European and Asian Popula- tions. Human molecular genetics 2009. 23. Zhang G, Goldblatt J, LeSouef PN: Does the relationship between IgE and the CD14 gene depend on ethnicity? Allergy 2008, 63(11):1411-1417. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/9/438/pre pub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 9 of 9 (page number not for citation purposes)